Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Macrogenics Inc’s stock clocked out at $14.56, up 1.32% from its previous closing price of $14.37. In other words, the price has increased by $1.32 from its previous closing price. On the day, 0.65 million shares were traded. MGNX stock price reached its highest trading level at $15.26 during the session, while it also had its lowest trading level at $14.22.
Ratios:
To gain a deeper understanding of MGNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on April 26, 2024, initiated with a Buy rating and assigned the stock a target price of $25.
BTIG Research reiterated its Buy rating for the stock on March 04, 2024, while the target price for the stock was revised from $12 to $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 04 ’24 when Peters Jeffrey Stuart sold 51,395 shares for $15.55 per share. The transaction valued at 799,148 led to the insider holds 0 shares of the business.
Peters Jeffrey Stuart sold 19,625 shares of MGNX for $421,938 on Mar 06 ’24. The Senior VP and General Counsel now owns 8,895 shares after completing the transaction at $21.50 per share. On Mar 04 ’24, another insider, Risser Eric Blasius, who serves as the Chief Operating Officer of the company, sold 41,159 shares for $19.76 each. As a result, the insider received 813,501 and left with 38,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGNX now has a Market Capitalization of 910880896 and an Enterprise Value of 713176128. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.50 while its Price-to-Book (P/B) ratio in mrq is 5.92. Its current Enterprise Value per Revenue stands at 12.139 whereas that against EBITDA is -4.497.
Stock Price History:
Over the past 52 weeks, MGNX has reached a high of $21.88, while it has fallen to a 52-week low of $4.29. The 50-Day Moving Average of the stock is -13.23%, while the 200-Day Moving Average is calculated to be 49.23%.
Shares Statistics:
It appears that MGNX traded 1.56M shares on average per day over the past three months and 789850 shares per day over the past ten days. A total of 62.07M shares are outstanding, with a floating share count of 58.71M. Insiders hold about 6.15% of the company’s shares, while institutions hold 94.70% stake in the company. Shares short for MGNX as of 1713139200 were 8599115 with a Short Ratio of 5.51, compared to 1710460800 on 5602561. Therefore, it implies a Short% of Shares Outstanding of 8599115 and a Short% of Float of 16.88.
